5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

 

5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology
J

Future Directions in Multiple Myeloma: Selinexor Approval, Venetoclax, Belantamab Mafodotin, BCMA:CD3 Bispecifics & CAR T

By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Jesus Berdeja
By 5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology FEATURING Jesus Berdeja
52 views
March 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Hematologic Malignancies
06:39
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Frontline Therapy in CLL: Obinutuzumab + Ibrutinib, Ibrutinib vs. Ch…

Feat. I. Flinn
07:09
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

ELEVATE TN Data on Acalabrutinib - Practice Changing Trial in CLL

Feat. I. Flinn
11:47
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Treatment Options for Newly Diagnosed Myeloma: Time to Incorporate C…

Feat. J. Berdeja
09:00
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Treatment Options in R/R Multiple Myeloma: Tips for Selecting Among …

Feat. J. Berdeja
12:36
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Future Directions in Multiple Myeloma: Selinexor Approval, Venetocla…

Feat. J. Berdeja
18:23
5th Annual West Oncology Conference at Graceland: Advances in the Business of Science of Oncology

Time Limited Therapy in CLL, Ibrutinib vs Zanubrutinib in WM & L…

Feat. I. Flinn